Conor J. Gallagher

1.2k total citations
47 papers, 799 citations indexed

About

Conor J. Gallagher is a scholar working on Neurology, Dermatology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Conor J. Gallagher has authored 47 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 18 papers in Dermatology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Conor J. Gallagher's work include Botulinum Toxin and Related Neurological Disorders (37 papers), Facial Rejuvenation and Surgery Techniques (16 papers) and Neurological disorders and treatments (10 papers). Conor J. Gallagher is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (37 papers), Facial Rejuvenation and Surgery Techniques (16 papers) and Neurological disorders and treatments (10 papers). Conor J. Gallagher collaborates with scholars based in United States, Canada and Ireland. Conor J. Gallagher's co-authors include Lee Ming Boo, Markus Naumann, Roman G. Rubio, Ava Shamban, Vic A. Narurkar, Nowell Solish, Shannon Humphrey, Susan Weinkle, Jean Carruthers and Steven Dayan and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of the American Academy of Dermatology.

In The Last Decade

Conor J. Gallagher

41 papers receiving 742 citations

Peers

Conor J. Gallagher

NEURO

DERMA

CMN

PHYSI

Ada Regina Trindade de Almeida Brazil

Philippe Kestemont France

Benjamin Ascher France

Sue Ellen Cox United States

Hervé Raspaldo France

Philippa Lowe United Kingdom

Konstantin Frank Germany

Rinky Kapoor India

André Braz United States

Deniz Yerdelen Türkiye

Ada Regina Trindade de Almeida Brazil

Conor J. Gallagher

628 ×1.1

NEURO

810 ×2.0

DERMA

70 ×0.5

CMN

215 ×1.9

PHYSI

67 ×0.7

Citations per year, relative to Conor J. Gallagher Conor J. Gallagher (= 1×) peers Ada Regina Trindade de Almeida

Countries citing papers authored by Conor J. Gallagher

Since Specialization

Citations

This map shows the geographic impact of Conor J. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conor J. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conor J. Gallagher more than expected).

Fields of papers citing papers by Conor J. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conor J. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conor J. Gallagher. The network helps show where Conor J. Gallagher may publish in the future.

Co-authorship network of co-authors of Conor J. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Conor J. Gallagher. A scholar is included among the top collaborators of Conor J. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conor J. Gallagher. Conor J. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McAllister, Peter, Atul T. Patel, Aaron Ellenbogen, et al.. (2025). Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN ‐Open‐Label Study. Movement Disorders Clinical Practice. 12(11). 1764–1773.

Mariwalla, Kavita, Ava Shamban, Jeremy B. Green, et al.. (2024). Clinical Benefits of DaxibotulinumtoxinA for Injection: Beyond Glabellar Line Effacement?. Dermatologic Surgery. 50(9S). S18–S23.

Dashtipour, Khashayar, et al.. (2024). Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. Toxins. 16(10). 442–442. 1 indexed citations

Gallagher, Conor J., et al.. (2024). Optimising for Sustainability as an Objective Function Within Airline Fleet Scheduling: An Ireland – EU Mobility Case Study. Trinity's Access to Research Output (TARA) (Trinity College Dublin).

Gallagher, Conor J., et al.. (2023). Biochemical Stability and Microbial Control of Reconstituted DaxibotulinumtoxinA-lanm for Injection. Toxins. 15(12). 683–683. 1 indexed citations

Gallagher, Conor J., et al.. (2023). Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins. 15(1). 60–60. 14 indexed citations

Humphrey, Shannon, et al.. (2023). Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines. Aesthetic Surgery Journal. 43(10). 1189–1193. 3 indexed citations

Solish, Nowell, Jean Carruthers, Joely Kaufman, et al.. (2021). Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs. 81(18). 2091–2101. 49 indexed citations

Bertucci, Vince, Nowell Solish, Joely Kaufman‐Janette, et al.. (2019). DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Journal of the American Academy of Dermatology. 82(4). 838–845. 47 indexed citations

10.

Carruthers, Jean, Steve Fagien, John Joseph, et al.. (2019). DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2). Plastic & Reconstructive Surgery. 145(1). 45–58. 48 indexed citations

11.

Keaney, Terrence, Robert Anolik, André Braz, et al.. (2018). The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns.. PubMed. 17(1). 19–28. 27 indexed citations

12.

Humphrey, Shannon, et al.. (2017). Preventive, Cumulative Effects of Botulinum Toxin Type A in Facial Aesthetics. Dermatologic Surgery. 43(3). S244–S251. 9 indexed citations

13.

Carruthers, Alastair, Suzanne Bruce, Sue Ellen Cox, et al.. (2016). OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review. Aesthetic Surgery Journal. 36(5). 591–597. 17 indexed citations

14.

Baumann, Leslie, et al.. (2016). Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines. Dermatologic Surgery. 42(5). 598–607. 16 indexed citations

15.

Rivers, Jason K., Vince Bertucci, Channy Muhn, et al.. (2015). Subject Satisfaction With OnabotulinumtoxinA Treatment of Glabellar and Lateral Canthal Lines Using a New Patient-Reported Outcome Measure. Dermatologic Surgery. 41(8). 950–959. 29 indexed citations

16.

Carruthers, Alastair, Neil S. Sadick, Ada Regina Trindade de Almeida, et al.. (2015). Evolution of Facial Aesthetic Treatment Over Five or More Years. Dermatologic Surgery. 41(6). 693–701. 29 indexed citations

17.

Narurkar, Vic A., et al.. (2015). Facial Treatment Preferences in Aesthetically Aware Women. Dermatologic Surgery. 41(Supplement 1). S153–S160. 53 indexed citations

18.

Marsh, Wallace, et al.. (2014). Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurology. 14(1). 91–91. 31 indexed citations

19.

Carruthers, Jean, et al.. (2014). Patient Satisfaction and Safety With Aesthetic OnabotulinumtoxinA After At Least 5 Years. Dermatologic Surgery. 41(Supplement 1). S19–S28. 35 indexed citations

20.

Naumann, Markus, et al.. (2012). Immunogenicity of botulinum toxins. Journal of Neural Transmission. 120(2). 275–290. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact